Apple has added new provisions to multiple sections of its Developer Program License Agreement, including Japan-specific terms, following yesterday’s announcement of changes to the App Store. Here’s ...

Apple on Wednesday released an updated developer license agreement that gives the company permission to recoup unpaid funds, such as commissions or any other fees, by deducting them from in-app ...

Software from an iPhone prototype running an early build of iOS 26 leaked last week, giving us a glimpse at future Apple devices and iOS features. We recapped device codenames in our prior article, ...

Walt Disney Co. is investing $1 billion in OpenAI under a new commercial partnership with the ChatGPT and Sora developer. The three-year licensing agreement will allow users of Sora, OpenAI's ...

Apple announced it will allow alternative app stores in Japan and will permit developers to process payments for digital goods and services outside of its own in-app purchase system in iOS. The iPhone ...

Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or watching a ...

Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or watching a ...

Leaked code from an unreleased build of iOS 26 reportedly contains references to several new features in the works for iOS 26.4 and iOS 27 next year. Here’s what the code reveals. Today, Espósito has ...

Lupin has inked an agreement with Valorum for biosimilar Armlupeg. Pegfilgrastim-unne is indicated to reduce the duration of neutropenia and the incidence of febrile neutropenia in patients receiving ...

It was the killer question for millions of iPhone users — has the time finally come when iOS 18 is no longer an option. You must update your iPhone — that is clear. Apple has warned devices are now ...

Biocerta Precision Diagnostics, Inc., a biotechnology company pioneering functional drug sensitivity testing (DST) to personalize cancer therapy, today announced two major business milestones: (1) an ...